机构:[1]Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China河南省肿瘤医院[2]School of Nursing, Jining Medical University, Jining, China[3]Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China四川省人民医院四川省肿瘤医院[4]Department of Public Health, Gansu Provincial Cancer Hospital, Lanzhou, China[5]Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China浙江省肿瘤医院[6]Department of Preventive Health, Xinxiang Central Hospital, Xinxiang, China[7]Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Beijing Office for Cancer Prevention and Control, Peking University Cancer Hospital & Institute, Beijing, China[8]The Clinical Epidemiology of Research Center, Department of Public Health and Preventive Medicine, Baotou Medical College, Baotou, China内蒙古科技大学包头医学院[9]Public Health School, Dalian Medical University, Dalian, China[10]Liaoning Office for Cancer Control and Research, Cancer Hospital of China Medical University, Liaoning Cancer Hospital and Institute, Shenyang, China[11]Department of Gastroenterology, Wuzhou Red Cross Hospital, Wuzhou, China[12]Department of Cancer Prevention and Control Office, The First Affiliated Hospital of Guangxi Medical University, Nanning, China[13]Department of Clinical Research, The First Affiliated Hospital, Jinan University, Guangzhou, China[14]Department of Student Affairs, Affiliated Tumor Hospital, Xinjiang Medical University, Ürümqi, China[15]State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China[16]Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, China[17]School of Public Health and Management, Chongqing Medical University, Chongqing, China[18]School of Public Health, Chengdu Medical College, Chengdu, China[19]Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Background: Colorectal cancer (CRC) poses a significant public health burden worldwide. The investigation of the choice of medical facility among CRC patients is helpful for understanding access to health services and improving quality of oncology services to optimize health outcomes. However, there are limited studies on the topic. The objective of this study was to investigate the choice of medical facility and its associated factors among advanced CRC patients. Methods: This cross-sectional multi-center study included a total of 4,589 individuals with advanced CRC from 19 hospitals in 7 geographic regions in China. Participants were recruited by multi-stage stratified sampling. In the first stage, two cities in each geographic region were selected through simple randomsampling. In the second stage, one tertiary cancer hospital and/or one general hospital were selected in each city. Data on medical experience and demographics were collected via a questionnaire during face-toface interviews. Explanatory variables were selected based on the Andersen behavioral model. Multinomial logistic regression analyses were performed to explore the factors associated with the level of medical facility for the first treatment. Results: Hospitals at the prefecture level were the most common medical facility sought by advanced CRC patients for initial medical care (44.9%), the first definite diagnosis (46.3%), the first treatment (39.5%), and regular follow-up (38.9%). However, the first priority was changed to hospitals at the national level for the second treatment (38.0%) and after recurrence and metastasis (45.9%). Female {odds ratios (ORs) ranged from 1.31 [95% confidence interval (CI): 1.01-1.71] to 1.41 [95% CI: 1.07-1.87]} and relatively welleducated individuals [ORs ranged from 1.74 (95% CI: 1.20-2.53) to 7.26 (95% CI: 4.18-12.60)] preferred to seek higher-level health facilities. Individuals with metastatic CRC at diagnosis were more likely to visit hospitals in provincial capitals versus hospitals at the county level (OR =1.68, 95% CI: 1.27-2.22). Individuals with "good" health-related quality of life (HRQOL) (OR =0.63, 95% CI: 0.49-0.81) were less likely to seek hospitals at the prefecture level compared with hospitals at the county level. Conclusions: There is a need to improve the oncology services for CRC patients, including the optimization of referral reform policy and the promotion of quality of primary healthcare service. The results may provide evidence to fill the policy-implementation gap and potentially contribute to the improvement of the efficiency of the healthcare system.
基金:
Beijing Love Book Cancer Foundation; Merck Serono Co. Ltd.
第一作者机构:[1]Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China
共同第一作者:
通讯作者:
通讯机构:[1]Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou, China[19]Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[*1]Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China[*2]Department of Cancer Epidemiology, Affiliated Cancer Hospital of Zhengzhou University/Henan Cancer Hospital, Henan Engineering Research Center of Cancer Prevention and Control, Henan International Joint Laboratory of Cancer Prevention, Zhengzhou 450008, China.[*3]Center for Global Health, School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
推荐引用方式(GB/T 7714):
Wang Xiao-Yang,Wang Wen-Jun,Zhao Yu-Qian,et al.The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study[J].ANNALS OF TRANSLATIONAL MEDICINE.2022,10(6):doi:10.21037/atm-22-1020.
APA:
Wang, Xiao-Yang,Wang, Wen-Jun,Zhao, Yu-Qian,Liu, Yin,Wang, Xiao-Hui...&China Working Group on Colorectal Cancer Survey.(2022).The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study.ANNALS OF TRANSLATIONAL MEDICINE,10,(6)
MLA:
Wang, Xiao-Yang,et al."The choice of medical facility and associated factors among Chinese advanced colorectal cancer patients: a cross-sectional multi-center study".ANNALS OF TRANSLATIONAL MEDICINE 10..6(2022)